Investments made in Puerto Rico by companies performing research and development activities totaled $449.3 million in Fiscal 2013, up 3.3 percent in comparison to the total reported in 2009, the Puerto Rico Statistics Institute revealed.
It was five years ago that manufacturing giant GlaxoSmithKline North America Pharmaceuticals took a step back to assess the way it was doing business.
The Puerto Rico Science, Research and Technology Trust and the government’s Chief Information Officer will work together to identify and evaluate research and development projects of high economic impact, which in turn may generate new marketable technologies, the entities announced Sunday.